Patent · US Active

Positive controls for expression modulating experiments

US8470998B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

QIAGEN GmbH · DE

Inventors

Peter Hahn · Bensberg, DE
Jörg Dennig · Langenfeld, DE
Wolfgang Bielke · Mechernich, DE
Jie Kang · Bonn, DE

Key dates

Filing date	Dec 29, 2008
Grant date	Jun 25, 2013
Priority date	—
Expiry date	Jan 31, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/10
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention pertains to the use of an apoptosis inducing combination of at least a. a first expression modulating compound silencing the expression of at least a first target gene involved in apoptosis and b. a second expression modulating compound silencing the expression of at least a second target gene involved in apoptosis as a positive control in expression modulating assays. Also provided are suitable methods, kits and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.